Details of the Drug

General Information of Drug (ID: DMR00J2)

Drug Name

PRGN-2012

Indication

Disease Entry	ICD 11	Status	REF
Respiratory papillomatosis	2F00.1	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04724980) A Phase 1/2 Study of Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis. U.S.National Institutes of Health.